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Abstract
The COVID-19 pandemic prompted the immediate widespread implementation of virtual care appointments in Cancer
Care Alberta (CCA). This study aimed to compare patient experiences and satisfaction with in-person care provided
prior to the pandemic and virtual care provided after the COVID-19 outbreak. Surveys were conducted to compare
patient satisfaction, using the Your Voice Matters (YVM) experience survey, between patients in the pre-pandemic inperson (baseline) and post-outbreak (virtual) cohorts. Generalized Linear Models (GLMs) with an ordinal logistic link
were used, adjusting for self-reported health status and other covariates, to investigate the association between cohort
type and patient satisfaction. Despite having higher overall health status, the virtual cohort reported statistically
significantly lower satisfaction than the baseline with emotional concerns, referrals and resources, and friend/family
involvement in their care. Patients in the virtual cohort were much less likely to have completed a routinely used
symptom-based Patient Reported Outcomes (PROs) questionnaire, which may help explain satisfaction differences. The
additional stressors brought about by the pandemic, as well as the mode of virtual care delivery, both likely contributed
to the lower satisfaction of the virtual cohort as well. Understanding the key differences in experience between the two
cohorts will inform the development of a larger virtual care strategy within CCA in the future.

Keywords
Patient experience, patient satisfaction, virtual care, cancer care, quality of life, health status, patient engagement,
COVID-19, quality improvement, patient reported outcomes

Background
COVID-19 has created unprecedented challenges for the
oncology community as the virus disproportionally harms
elderly persons and those with comorbid conditions,
including cancer.1 Given the need for social distancing and
exposure mitigation, many cancer facilities quickly
incorporated virtual appointments wherever possible to
replace in-person appointments, which was the primary
mode of care delivery prior to the pandemic. Cancer Care
Alberta (CCA), a publicly funded provincial cancer
program, provides care to patients through a network of
17 ambulatory cancer centres. By mid-March 2020, CCA
had integrated the capacity for clinicians to convert inperson appointments to virtual appointments using
telephone, telehealth or video-based platforms such as
Zoom or Skype 2; out of convenience, most virtual
appointments were conducted over the telephone.
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Although CCA had been planning to eventually increase
the use of virtual care in the future, its integration was
rapidly accelerated during the pandemic. With the rate of
COVID-19 infections continuing to fluctuate in Alberta,
the impacts and consequences of the pandemic are sure to
be long-lasting, and CCA plans to continue utilizing virtual
care in the future.3,4 Because of this, ensuring that patients
are highly satisfied with the ambulatory cancer care they
receive, regardless of whether they are seen in-person or
virtually, is of critical importance.

Historical Use of Patient Reported Outcomes to
Improve Patient Experience

Person-centred care has been a priority in CCA for many
years, and the routine utilization of Patient Reported
Outcomes (PROs) within clinical assessment is a key
driver of this approach.5 CCA uses a PROs questionnaire
with two specific measures that track patients’ symptoms
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and concerns.6,7,8 Patients complete the paper
questionnaire in the waiting room prior to clinic
appointments. The questionnaire is then reviewed in the
clinical encounter to help focus the appointment on the
symptoms and concerns that the patient considers most
relevant. It is then transcribed into an electronic
questionnaire template within CCA’s Electronic Medical
Record (EMR) by a staff member. The PROs data can be
viewed via digital dashboards which allow symptoms to be
tracked longitudinally, enabling staff to view patients’
symptom trends prior to the appointment and then tailor
the visit to a patient’s individual needs.5,9,10 Using PROs
data in this way has been shown to improve clinical
outcomes and survival11 and improve patient experiences
and satisfaction5,12,13 After implementation of the PROs
questionnaire and the associated dashboards, CCA
conducted a nearly year-long Quality Improvement (QI)
investigation to assess the impact of these tools on the
patient experience. Randomly selected ambulatory cancer
patients were surveyed between February 2019 and
January 2020. The details of this survey will be discussed
later in this paper.

To better understand how patient experiences may have
been impacted by the rapid virtual care implementation, a
strategy to conduct a patient experience evaluation was
developed, focusing on patients who received a virtual
appointment in the early months of the COVID-19
pandemic. As a similar QI initiative had recently been
conducted to evaluate experiences with in-person clinical
appointments after implementation of the PRO tools, a
unique opportunity for comparison arose.

Rapid Virtual Care Implementation and the
Disruption of Standard Care Practices

Methods

Because virtual care was implemented rapidly as a
pandemic response, the QI team questioned whether
patient experiences with virtual care were equivalent to
those who received standard in-person care prior to the
pandemic. At the time, many cancer programs, including
CCA, did not have established protocols for determining
which appointments should shift to virtual care14 and it is
likely that this decision was often left up to the discretion
of the provider. This assumption is reinforced by recent
studies indicating that, without standard protocols in place,
patient preference and provider judgement largely
determined which patients would receive virtual care.14,15
Importantly, Reddy et al. (2021) suggest that not all
patients are suited to virtual appointments, particularly if
they have considerable distress or would benefit from a
full physical examination.16 A recent survey conducted
with CCA staff similarly indicated that they believed stable
patients with few complications, or those on follow-up
rather than active treatment, were best suited for virtual
appointments.15
Just as the process for assigning patients to virtual care was
rather ad hoc, so was the process for having patients
complete the PROs questionnaire virtually. The workflow
for this questionnaire relies on in-person appointments,
and with no clear guidelines for shifting this process to
virtual settings, there was an inevitable reduction in use of
the PROs tools.15 There was interest in understanding how
this impacted the patient experience, if at all, as clinicians
would have less visibility of the issues patients considered
most concerning, without a completed questionnaire to
review.
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Study Purpose

Virtual care will remain part of CCA’s model of care
beyond the pandemic, and with the rate of COVID-19
infections in Alberta continuously changing, the impacts of
the pandemic will be long-lasting. Consequently, the
purpose of this study was to compare patient satisfaction
with in-person ambulatory oncology care across CCA
prior to the pandemic, to patient satisfaction with virtual
cancer care during the pandemic. The goal of this
comparison was to gain valuable insights to inform
ongoing efforts to improve virtual care and patient
experiences after the pandemic and into the future.

Procedure

A quasi-experimental research study was conducted to
compare two cohorts: an in-person, pre-pandemic
(baseline) cohort and a (virtual) cohort who received
virtual care during the pandemic. All participants were
cancer patients who received care from any of the 17
cancer centres in CCA. Both cohorts received similar
surveys, consisting of satisfaction questions from Your
Voice Matters (YVM), a validated, real-time patient
experience survey.17 Given the possibility that the virtual
cohort was made up of generally “healthier” patients 15 and
the potential impact of health status on satisfaction, the
surveys also included the EuroQol five-Dimension – Five
Level (EQ5D-5L), a validated self-rated measure of health
status.18 The survey for the baseline cohort also included
additional questions about the use and value of the PROs
questionnaire and PROs dashboards in their appointment,
while the virtual survey included targeted questions about
various aspects of virtual care. For the purposes of
comparison, we only analyzed responses to the questions
that were the same on both surveys.
Data Collection – Baseline Cohort: Data collection for the
baseline cohort occurred from February 2019 to January
2020. Patients who had an in-person clinic appointment in
this time period, and who completed a PROs
questionnaire at their appointment, were eligible for
inclusion. Patients who met these criteria were randomly
selected and surveyed via telephone, with the caller
recording responses into an online questionnaire.
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Data Collection – Virtual Cohort: Data collection for the
virtual cohort occurred from May 2020 to July 2020 (note
that the start of the pandemic in Alberta was March 2020).
All patients who had a virtual appointment in this time
period were eligible for inclusion. Patients who had a
virtual appointment within the previous week were
randomly selected and surveyed via telephone, following
the same process as the baseline cohort.
For both cohorts, patient characteristics including age, sex,
tumour group, whether treatment was received in the past
three months (yes/no), and which cancer centre was
visited (either in-person or virtually) were retrieved from
the CCA administrative database. Self-rated health status
was also measured for both cohorts, using the EQ5D-5L.
The first component of this validated measure is
descriptive and comprised of five dimensions of health
status (mobility, self-care, usual activities, pain/discomfort,
and anxiety/depression). The second is a visual analogue
scale (EQ-VAS) where respondents record their self-rated
health from 0-100 with zero being the “Worst health you
can imagine” and 100 being the “Best health you can
imagine.”19 There are different ways of analyzing and
reporting data from EQ5D-5L, including reporting only
the EQ-VAS scores; this method of reporting was utilized
in the current study, as health status was included as a
control variable rather than an outcome measure.20
Collecting this data concurrently with the YVM allowed
for an examination of the impact of self-rated health status
on patient experience.21
An Alberta Research Ethics Community Consensus
Initiative (ARECCI) screening tool was used to assess any
ethical risk associated with this project. The work was
deemed minimal risk and classified as a QI and
Evaluations project which did not require additional
precautions or full ethics review.22

Outcome Measures

The outcome measure in this study was patient experience,
as measured by the YVM survey questions. The YVM
survey is a 28-item questionnaire for adult cancer
outpatients undergoing treatment, developed by Cancer
Care Ontario.17 The YVM uses a 5-point Likert scale to
assess patient satisfaction in specific areas of the care
experience, with answers ranging from 1 (“Worst”) to 5
(“Best”). For our purposes, two sections from the original
survey were used: “Appointment/Treatment” (11
questions) and “Overall Experience” (1 question). The
questions in these sections were directly related to our goal
of understanding the patient experience both in-person
and virtually. The Cronbach alpha of reliability23 for
“Appointment/Treatment” was .952 for the baseline
cohort and .910 for the virtual cohort, indicating strong
internal consistency, and validated the use of these
questions for the current study.
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Statistical Analyses

Patient characteristics and self-rated health status were
presented using descriptive statistics and compared
between the two cohorts using independent t-tests for
continuous variables, chi-square tests for categorical
variables and Mann-Whitney U tests for ordinal variables.
As many of the responses were ordinal in nature,
Generalized Linear Models (GLMs) with ordinal logistic
link were carried out to test the differences in the 11
patient satisfaction questions and the 1 overall experience
question between the two cohorts, adjusting for all
confounders. Model goodness-of-fit was assessed by the
value of Deviance/df. In practice, a model is found
acceptable if Deviance/df <2.5.24 Data were exported into
SPSS Version 25.0 for analysis and statistical significance
was set a priori at p <.05.

Results
Sample Characteristics

The baseline cohort (n=292) was 58.6% female and the
mean age was 63.6 years (SD = 13.4 and IQR: 57.00 72.75). The most common tumour group was hematology
(24.0%), followed by gastrointestinal (19.5%) and breast
(18.2%). More than two-thirds (69.5%) were on active
treatment in the 3 months before the survey took place.
Just over half (52.1%) of the patients in this cohort visited
one of the two tertiary cancer centres in the province, and
the rest (47.9%) visited either a regional or community
cancer centre. The mean EQ-VAS score was 68.5 out of a
maximum of 100. All patients in this cohort completed a
PROs questionnaire at their appointment.
The virtual cohort included 397 cancer patients who had at
least one virtual appointment after the start of the
COVID-19 pandemic. This cohort was 51.6% female and
the mean age was 63.8 years (SD = 13.8 and IQR: 58.00 73.00). The most common tumour group was hematology
(25.9 %), followed by breast (15.9%) and gastrointestinal
(14.6%). Less than half (42.3%) of those in the virtual
cohort were on active treatment in the 3 months before
the survey took place. Nearly three-quarters (72.5%) had
their virtual appointment with one of the two tertiary
cancer centres in the province and the remaining (27.5%)
had their virtual appointment with a regional or
community cancer centre. The mean EQ-VAS score was
73.2 out of 100. The percentage of patients in the virtual
cohort who completed the PROs questionnaire in relation
to their virtual appointment was 16.9%.
The two cohorts significantly differed on three factors:
treatment status, cancer centre visited, and self-reported
health status (measured by the EQ-VAS). A significantly
larger proportion of the baseline cohort was on active
treatment as compared to the virtual cohort (69.5%
compared to 42.3%). Just over half of the baseline cohort
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Table 1. Patient characteristics by cohort
Baseline cohort
Virtual cohort
p
Age in years
.844
M (SD, IQR)a
63.6 (13.4, 57.00 - 72.75)
63.8 (13.8, 58.00 - 73.00)
Sex
Female
171 (58.6%)
205 (51.6%)
.071
Male
121 (41.4%)
192 (48.4%)
Tumour groups
.061
Breast
53 (18.2%)
63 (15.9%)
Gastrointestinal
57 (19.5%)
58 (14.6%)
Genitourinary
36 (12.3%)
55 (13.9%)
Gynecology
21 (7.2%)
15 (3.8%)
Hematology
70 (24.0%)
103 (25.9%)
Intrathoracic
29 (9.9%)
45 (11.3%)
Otherb
26 (8.9%)
58 (14.6%)
Treatment in last 3 months
.000
Yes
203 (69.5%)
168 (42.3%)
No
89 (30.5%)
229 (57.7%)
Cancer centre visited
Tertiary cancer centre
152 (52.1%)
288 (72.5%)
.000
Regional/community cancer centre
140 (47.9%)
109 (27.5%)
EQ-VAS score (0-100)
M (SD, IQR)a
68.5 (19.9, 50.00 - 85.00)
73.2 (19.8, 60.00 - 90.00)
.003
a: M = mean, SD = standard deviation, IQR = interquartile range
b: “Other” included central nervous system, endocrine, head & neck, melanoma, non-melanoma skin, other
primary and sarcoma.
visited a tertiary cancer centre (52.1%), compared with
nearly three-quarters of the virtual cohort (72.5%). Finally,
the baseline cohort reported significantly lower EQ-VAS
scores (M = 68.5, SD = 19.9) than the virtual cohort (M =
73.2, SD = 19.8), (t =3.00, p <.01), indicating that the
baseline cohort self-rated their overall health lower. Table
1 presents the significance level of the examined
demographic and clinical characteristics between the two
cohorts.

Patient Satisfaction and Experience by Cohort

All demographic and clinical variables listed in Table 1
were included in the multivariable generalized linear model
as covariates, to assess the difference in patient experience
between the two cohorts. The model fit value
(Deviance/df) of the 12 GLMs ranged from 0.131 to
0.954, all below the threshold of 2.5, indicating the data fit
the model well.24
Table 2 presents the results of GLMs outlining differences
in patient experience between the two cohorts. Out of the
11 satisfaction and 1 overall experience questions, the
virtual cohort significantly differed from the baseline
cohort on three questions. Specifically, the virtual cohort
reported significantly lower satisfaction with “Emotional
Concerns Discussed”, (OR: .731; 95% CI: .620-.863; p
<.01); “Friend/Family Involvement”, (OR: .814; 95% CI:
.734-.902; p <.01) and “Resources & Referrals”, (OR: .596;
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95% CI: .494-.718; p <.01). There were no statistically
significant differences between the two cohorts on the
other seven satisfaction questions or on the overall
experience question. The virtual cohort did not report
significantly higher satisfaction than the baseline cohort on
any questions.

Discussion
The rapid integration of virtual care within CCA took
place in only a few weeks, to ensure patient safety during
the COVID-19 pandemic.2 Virtual appointments increased
considerably from the start of the pandemic, with around
40% of appointments taking place virtually on a given
week.15 While patient safety remains a priority, it is also
important to ensure that efforts are taken wherever
possible to ensure that patient equity, experience and
satisfaction are maintained with both in-person and virtual
appointments, as CCA plans to utilize virtual care beyond
the pandemic and into the future.

Emotional Concerns

Based on results from a nationally validated province-wide
patient experience survey regularly distributed within CCA,
discussing patients’ emotional worries and concerns has
often been flagged as an area for improvement.25,26 The
integration of the routine use of a PROs questionnaire,
and the associated clinical dashboards within CCA, was
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Table 2. Summary of the GLM results (patient satisfaction)
YVM questions
Listened to you
Physical discussion
Emotional concerns discussed*
Treated with respect
Spent enough time
Explained things well
Involved you
Let you ask questions
Friend/family involvement*
Resources & referrals*
Ensured contacts
Overall experience

OR (95% CI)
Baseline cohorta
Virtual cohort
1
.992 (.916 - 1.07)
1
.972 (.890 - 1.06)
1
.731 (.620 - .863)
1
.978 (.922 - 1.04)
1
.980 (.906 - 1.06)
1
.990 (.919 - 1.07)
1
1.01 (.919 - 1.10)
1
.970 (.910 - 1.03)
1
.814 (.734 - .902)
1
.596 (.494 - .718)
1
.960 (.850 - 1.08)
1
.958 (.870 - 1.05)

Wald χ2
.036
.390
13.66
.546
.241
.079
.023
.861
15.39
29.38
.429
.795

SEb
.040
.045
.085
.030
.040
.038
.047
.033
.053
.096
.062
.049

p
.850
.532
<.01
.460
.623
.779
.879
.354
<.01
<.01
.512
.372

a: Reference group
b: Standard Error
*: Results with significant differences between cohorts

driven by an organizational commitment to improve
patient outcomes and satisfaction with this aspect of their
care. By identifying patients’ emotional concerns,
appropriate discussions can take place and referrals to
supportive care services can be made accordingly.
However, as the use of the PROs questionnaire currently
relies on an in-person workflow, virtual care had a
dramatic negative impact on its use. Alternative delivery
methods were explored, such as having a staff member
contact the patient prior to their appointment to complete
the questionnaire via telephone, however these methods
were labour intensive and largely unfeasible. Only 16.9%
of patients in the virtual cohort completed a PROs
questionnaire in relation to their appointment, while
average in-person completion rates were about 75% prepandemic, and 55% for in-person appointments during the
pandemic.15 Patients in the virtual cohort who did not
complete the PROs questionnaire may not have had a
targeted discussion about symptoms, particularly
emotional symptoms, while the baseline cohort were much
more likely to have had a targeted discussion, as the
regular completion of PROs was part of the inclusion
criteria for this cohort. This would help explain why the
virtual cohort was less satisfied with the discussion of their
emotional concerns during their visit. Providing emotional
support and addressing sensitive topics can also be more
difficult in virtual appointments, particularly when
conducted using the telephone, rather than a video-based
platform.15
The pandemic itself likely also contributed to the virtual
cohort’s lower satisfaction with the emotional support they
were provided. COVID-19 wreaked havoc on the mental
well-being of many people by introducing new stressors
and fears,27,28 perhaps even more so for people who were
already dealing with a complicated cancer diagnosis.29,30
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These patients may have had more emotional concerns
than usual and in turn needed, or wanted, additional
interventions to feel sufficiently supported.27 The value of
PROs in identifying and addressing patients’ emotional
needs has been clearly demonstrated; therefore, use of the
PROs questionnaire may have been even more important
during the pandemic, given the added stressors, but its use
was disrupted by the virtual format of care delivery.

Referrals and Resources

As mentioned, patients who received virtual care also had
significantly lower levels of satisfaction with their
connection to referrals and resources. Another recent
study conducted within CCA compared patients who
received virtual care to patients who received in-person
care during the first wave of COVID-19 and found that
fewer referrals were made for virtual patients than inperson patients in the same time period.15 Based on this,
we can reasonably assume that the virtual cohort in the
current study also received lower numbers of referrals.
The low completion rate of PROs questionnaires may be
one reason for this, as staff rely on the results and the
electronic transcription of the questionnaire into the EMR
to guide the referrals they make.31
Another explanation could be that the added stressors
brought on by the pandemic, combined with the
accompanying lack of social interaction, resulted in virtual
patients feeling as though they wanted additional support.
It is possible that staff did not recognize this due to the
virtual cohort being in better overall health, both in terms
of their self-rated EQ-VAS scores and their lower
likelihood of being on active treatment (with patients on
treatment often having high associated symptom
burdens).32 Their higher self-rated health status may have
led staff to believe these patients did not need additional
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referrals or resources. Had staff known then, as we do
now, that the virtual cohort felt less satisfied with how
their emotional needs and concerns were addressed, they
may have been more likely to connect these patients to
emotional and/or supportive care resources for support.
This highlights the need to look beyond physical health
status when deciding which patients should be referred to
additional services, as patients who are technically
“healthier” may still want – and benefit from – additional
resources and referrals.

Family and Friend Involvement

Many patients rely on family, friends, and caregivers in
some capacity to help them navigate the cancer system,
often during their appointments. This can be even more
prevalent among older patients, which is particularly
relevant as the mean age of both cohorts in this study was
just over 63 years old.33,34 During the pandemic, patients
would likely not have had the same access to these
supports as they normally would have, unless friends or
family members resided within the same household, as
social distancing was one of the primary strategies in place
to mitigate the spread of COVID-19 in Alberta. In some
situations, friends or family members may have joined
virtual appointments from a different location, however
this was likely not feasible for many patients. As a result,
patients probably felt isolated from their usual support
system, which likely contributed to their decreased
satisfaction regarding the involvement of friends and
family in their care. We also know from other studies that
emotional support provided virtually may not fully meet
patient needs.15
As COVID-19 continues to impact the health care system
in Alberta, development of a comprehensive virtual care
strategy is currently underway within CCA. The goal is to
incorporate virtual care as an everyday part of care delivery
in the future, rather than only as a supplementary or
emergency care method. Understanding which aspects of
the current virtual care process are in need of
improvement is therefore critical to ensure that patients
receive tailored person-centred care regardless of which
platform of care delivery is used, while ensuring that
positive experiences and a high level of patient satisfaction
are maintained.

Limitations

The primary limitation of this study is that it is not
possible to conclude if virtual care or the pandemic itself
played a larger role in influencing patient satisfaction, as
the cohorts differed on more than one factor. The baseline
cohort was surveyed prior to the pandemic, received inperson care, and completed a PROs questionnaire, while
the virtual cohort was surveyed during the pandemic,
received virtual care, and had low rates of questionnaire
completion; therefore, no single factor can be isolated as
the primary cause of the between-cohort differences. All
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of these factors must be considered when creating a larger
virtual care strategy. It will be important to repeat a similar
patient survey in the near future to assess differences in
patient satisfaction as virtual care increasingly becomes
implemented as a routine part of care delivery, rather than
as a rapid response to COVID-19. This will allow CCA to
better understand which aspects of virtual care have been
beneficial, and which aspects may require additional
modifications.

Conclusion
Person-centred care is a priority in CCA, and regularly
assessing patient satisfaction and collecting feedback on
the patient experience is a key strategy for ensuring that
this priority is met. Whether the incidence of COVID-19
remains high in Alberta or begins to decrease, virtual care
will continue to take place in the future, with an emphasis
on ensuring patient needs are being met through this
mode of care delivery within CCA. In particular, strategies
should be explored to determine the most efficient and
effective way to administer and collect PROs virtually, as
the proven value of the routine questionnaire has clear
impacts on patient outcomes and experience. Additionally,
ensuring that supportive care resources are offered to
patients both on-treatment and on follow-up, regardless of
whether they are seen virtually or in-person, is essential to
meeting patients’ needs and ensuring satisfaction with their
care. Comparing patient satisfaction is important to
understand the current gaps with virtual care and inform
the design of a larger and more encompassing virtual care
strategy. Identifying gaps in virtual care can also inform
improvements in the delivery of in-person care, as the goal
is to ensure that patient needs are met and patient
satisfaction is high, regardless of how care is delivered.
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